(DNTH) Dianthus Therapeutics - Performance -28.7% in 12m
DNTH performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-80.55%
#134 in Peer-Group
Rel. Strength
16.98%
#6392 in Stock-Universe
Total Return 12m
-28.73%
#96 in Peer-Group
Total Return 5y
-86.46%
#103 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 29.90 USD |
| 52 Week Low | 14.86 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 71.74 |
| Buy/Sell Signal +-5 | 0.82 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: DNTH (-28.7%) vs XBI (-6.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
5.64% | 38.5% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: DNTH vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DNTH
| Total Return (including Dividends) | DNTH | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 7.16% | 3.53% | 5.22% |
| 3 Months | 11.08% | 9.10% | 16.86% |
| 12 Months | -28.73% | -6.17% | 14.81% |
| 5 Years | -86.46% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | DNTH | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -9.5% | 4.4% | 81% |
| 3 Months | -23.6% | 78.8% | 96.9% |
| 12 Months | -89.7% | -85.8% | 44.9% |
| 5 Years | -65.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th68.00 | 3.51% | 1.85% |
| 3 Month | %th51.50 | 1.82% | -4.95% |
| 12 Month | %th52.50 | -24.05% | -37.93% |
| 5 Years | %th48.50 | -82.13% | -93.61% |
FAQs
Does Dianthus Therapeutics (DNTH) outperform the market?
No,
over the last 12 months DNTH made -28.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months DNTH made 11.08%, while XBI made 9.10%.
Performance Comparison DNTH vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
DNTH vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.8% | 1.9% | -31.2% | -44% |
| US NASDAQ 100 | QQQ | 2.1% | 1.6% | -32.5% | -43% |
| German DAX 40 | DAX | 2.8% | 7.8% | -44.7% | -58% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.5% | 3% | -34.1% | -47% |
| Hongkong Hang Seng | HSI | 2.7% | 0.8% | -49.6% | -64% |
| India NIFTY 50 | INDA | 3.8% | 3.8% | -29.5% | -28% |
| Brasil Bovespa | EWZ | -0.2% | -1.1% | -58% | -40% |
DNTH vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.5% | 0.6% | -35.9% | -56% |
| Consumer Discretionary | XLY | 1.1% | 4.3% | -23.4% | -48% |
| Consumer Staples | XLP | 1.5% | 7.2% | -31.2% | -39% |
| Energy | XLE | 2.5% | 2.2% | -26.1% | -27% |
| Financial | XLF | 1.3% | 2.7% | -35.2% | -59% |
| Health Care | XLV | 3% | 4.8% | -23.3% | -25% |
| Industrial | XLI | 1.2% | 2.9% | -38.2% | -53% |
| Materials | XLB | -0.1% | 2.5% | -35.9% | -35% |
| Real Estate | XLRE | 1.9% | 5.9% | -28.9% | -42% |
| Technology | XLK | 1.6% | -1.7% | -34.3% | -40% |
| Utilities | XLU | 3.1% | 7.2% | -32.6% | -52% |
| Aerospace & Defense | XAR | 3% | -0.5% | -48.4% | -78% |
| Biotech | XBI | 2.1% | 3.6% | -17.2% | -23% |
| Homebuilder | XHB | -1.2% | -1.4% | -23.4% | -33% |
| Retail | XRT | -1.3% | 2.9% | -26.7% | -40% |
DNTH vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.8% | -0.42% | -21.5% | -21% |
| Natural Gas | UNG | 6.6% | 17.2% | -22.8% | -22% |
| Gold | GLD | 3.9% | 7.7% | -51.1% | -70% |
| Silver | SLV | 3.5% | 0.6% | -49.2% | -49% |
| Copper | CPER | 3.3% | 2.2% | -49.9% | -42% |
DNTH vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.7% | 4.5% | -26.8% | -28% |
| iShares High Yield Corp. Bond | HYG | 3.5% | 5.4% | -29.7% | -39% |